Effects of direct-to-consumer advertising and clinical guidelines on appropriate use of human papillomavirus DNA tests

Medical Care

Volumn 49, Issue 2, 2011, Pages 132-138

  Price, Rebecca Anhang ^a   Frank, Richard G ^b,c   Cleary, Paul D ^d   Goldie, Sue J ^e  

^a RAND CORPORATION   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c U S DEPARTMENT OF HEALTH AND HUMAN SERVICES   (United States)

^d YALE UNIVERSITY   (United States)

^e HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

appropriate use; clinical guidelines; consumer marketing; medical technologies

Indexed keywords

VIRUS DNA;

ADULT; ADVERTIZING; ARTICLE; CANCER SCREENING; CONSUMER HEALTH INFORMATION; FEMALE; HEALTH CARE UTILIZATION; HUMAN; PRACTICE GUIDELINE; PRIORITY JOURNAL; UTERINE CERVIX CANCER; WART VIRUS;

ADULT; ADVERTISING AS TOPIC; ALPHAPAPILLOMAVIRUS; DNA, VIRAL; FEMALE; GUIDELINE ADHERENCE; HEALTH SERVICES MISUSE; HEALTH SERVICES RESEARCH; HUMANS; INSURANCE CLAIM REPORTING; LOGISTIC MODELS; MARKETING OF HEALTH SERVICES; MASS SCREENING; MIDDLE AGED; PAPILLOMAVIRUS INFECTIONS; PHYSICIAN'S PRACTICE PATTERNS; PRACTICE GUIDELINES AS TOPIC; UNITED STATES; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS;

EID: 78751631168     PISSN: 00257079     EISSN: None     Source Type: Journal    
DOI: 10.1097/MLR.0b013e3181f81c63     Document Type: Article

References (27)

1. Institute of Medicine. Crossing the Quality Chasm: A New Health System for the 21st Century. Washington, DC: National Academy Press; 2001.
2. Weisz G, Cambrosio A, Keating P, et al. The emergence of clinical practice guidelines. Milbank Q. 2007;85:691-727
3. Davis DA, Taylor-Vaisey A. Translating guidelines into practice. A systematic review of theoretic concepts, practical experience and research evidence in the adoption of clinical practice guidelines. CMAJ. 1997;157:408-416
4. Donohue JM, Cevasco M, Rosenthal MB. A decade of direct-to-con-sumer advertising of prescription drugs. N Engl J Med. 2007;357:673-681
5. Pharmaceutical Research and Manufacturers of America. PhRMA Guiding Principles: Direct to Consumer Advertisements about Prescription Medicines. http://www.phrma.org/files/attachments/PhRMA%20Guiding% 20Principles-Dec%2008- FINAL.pdf. 2009. Cited October 27, 2010
6. Hollon MF. Direct-to-consumer advertising: a haphazard approach to health promotion. JAMA. 2005;293:2030-2033
7. Division of Adult and Community Health. Behavioral Risk Factor Surveillance system online prevalence data, 1995-2004. 2004. Available at: http://apps.nccd.cdc.gov/brfss/index.asp
8. Sirovich BE, Welch HG. The frequency of Pap smear screening in the United States. J Gen Intern Med. 2004;19:243-250
9. U.S. Preventive Services Task Force. Guide to Clinical Preventive Services. 3rd ed. Washington, DC: US Department of Health and Human Services; 2003.
10. Wright TC Jr, Cox JT, Massad LS, et al. 2001 Consensus guidelines for the management of women with cervical cytological abnormalities. JAMA. 2002;287:2120-2129
11. American College of Obstetricians and Gynecologists. ACOG Practice Bulletin: clinical management guidelines for obstetrician-gynecologists. Number 45, August 2003. Cervical cytology screening (replaces committee opinion 152, March 1995). Obstet Gynecol. 2003;102:417-427
12. Saslow D, Runowicz CD, Solomon D, et al. American Cancer Society guideline for the early detection of cervical neoplasia and cancer. CA Cancer J Clin. 2002;52:342-362
13. Wright TC Jr, Schiffman M, Solomon D, et al. Interim guidance for the use of human papillomavirus DNA testing as an adjunct to cervical cytology for screening. Obstet Gynecol. 2004;103:304-309
14. U.S. Food and Drug Administration. FDA Approves expanded use of HPV test. 2003. Available at: http://www.fda.gov/bbs/topics/NEWS/2003/NEW00890.html. Accessed February 15, 2008
15. Nielsen Media Research. Glossary. 2008. Available at: www.nielsenmedia. com/nc/nmr-portal/t27/glossary.jsp?site=Public&session=no-forward& letter=D. Accessed July 24, 2008
16. Adamson D, Chang S, Hansen L. Health Research Data for the Real World: the MarketScan Databases. New York, NY: Thomson Reuters Healthcare; 2008
17. Fitzmaurice G, Laird N, Ware J. Applied Longitudinal Analysis (Wiley Series in Probability and Statistics). Hoboken, NJ: John Wiley & Sons; 2004
18. Ai C, Norton EC. Interaction terms in logit and probit models. Econ Lett. 2003;80:123-129
19. Efron B, Tibshirani R. An Introduction to the Bootstrap. Boca Raton, FL: CRC Press; 1998
20. Spence MM, Teleki SS, Cheetham TC, et al. Direct-to-consumer advertising of COX-2 inhibitors: effect on appropriateness of prescribing. Med Care Res Rev. 2005;62:544-559
21. Kravitz RL, Epstein RM, Feldman MD, et al. Influence of patients' requests for direct-to-consumer advertised antidepressants: a randomized controlled trial. JAMA. 2005;293:1995-2002
22. Block AE. Costs and benefits of direct-to-consumer advertising: the case of depression. Pharmacoeconomics. 2007;25:511-521
23. Kaphingst KA, DeJong W. The educational potential of direct-to-consumer prescription drug advertising. Health Aff (Millwood). 2004; 23:143-150
24. Schwartz LM, Woloshin S, Welch HG. Using a drug facts box to communicate drug benefits and harms: two randomized trials. Ann Intern Med. 2009;150:516-527
25. Weissman JS, Blumenthal D, Silk AJ, et al. Physicians report on patient encounters involving direct-to-consumer advertising. Health Aff (Millwood). 2004;Suppl Web Exclusives:W4-219-W4-233
26. Murray E, Lo B, Pollack L, et al. Direct-to-consumer advertising: physicians' views of its effects on quality of care and the doctor-patient relationship. J Am Board Fam Pract. 2003;16:513-524
27. U.S. Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research. Patient and Physician Attitudes and Behaviors Associated With DTC Promotion of Prescription Drugs: Summary of FDA Survey Research Results. Washington, DC: US Department of Health and Human Services. Food and Drug Administration. Center for Drug Evaluation and Research; 2004. Available at: http://www.fda.gov/CDER/ddmac/researchka.htm